序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
1 |
22244-14-0 |
Ferristatin II |
≥98% |
|
询价 |
2 |
22255-13-6 |
Guaijaverin |
≥98% |
|
询价 |
3 |
22255-22-7 |
trans-Trimethoxyresveratrol |
≥98% |
|
询价 |
4 |
2225728-57-2 |
FT895 |
≥98% |
|
询价 |
5 |
2225887-26-1 |
EGFR-IN-5 |
≥98% |
|
询价 |
6 |
2169272-46-0 |
KDM2A/7A-IN-1 |
≥98% |
|
询价 |
7 |
217087-09-7 |
Esomeprazole Magnesium trihydrate |
≥98% |
|
询价 |
8 |
13993-65-2 |
Metiazinic acid |
≥98% |
|
询价 |
9 |
67644-00-2 |
Prolylglutamic acid |
≥98% |
|
询价 |
10 |
959746-77-1 |
A-836339 |
≥98% |
|
询价 |
11 |
122836-35-5 |
Sulfentrazone |
≥98% |
|
询价 |
12 |
1050-28-8 |
Tyrosyltyrosine |
≥98% |
|
询价 |
13 |
1830-32-6 |
Azintamide |
≥98% |
|
询价 |
14 |
63951-20-2 |
Ammonium,(4-(p-trimethylammoniophenyl)butyl)trimethyl-,diiodide |
≥98% |
|
询价 |
15 |
568526-77-2 |
KRH-1636 |
≥98% |
|
询价 |
16 |
219769-23-0 |
SB-284851-BT |
≥98% |
|
询价 |
17 |
6882-07-1 |
Salicifoline |
≥98% |
|
询价 |
18 |
803735-54-8 |
AZ-1 |
≥98% |
|
询价 |
19 |
150-13-0 |
Aminobenzoic acid |
≥98% |
|
询价 |
20 |
928007-64-1 |
Acetyl tetrapeptide-15 |
≥98% |
|
询价 |
21 |
148-18-5 |
Ditiocarb sodium |
≥98% |
|
询价 |
22 |
156691-86-0 |
AGN-191659 |
≥98% |
|
询价 |
23 |
635318-26-2 |
Pomaglumetad methionil HCl |
≥98% |
|
询价 |
24 |
118458-54-1 |
Arcyriaflavin A |
≥98% |
|
询价 |
25 |
62989-33-7 |
Sapropterin |
≥98% |
|
询价 |
26 |
1052087-90-7 |
PSB-0739 sodium |
≥98% |
|
询价 |
27 |
27226-50-2 |
PYR-6502 |
≥98% |
|
询价 |
28 |
90947-89-0 |
AG 127 |
≥98% |
|
询价 |
29 |
|
ENMD-2076 HCl |
≥98% |
|
询价 |
30 |
2144425-14-7 |
IACS-8968 |
≥98% |
|
询价 |
31 |
214548-46-6 |
Lusaperidone |
≥98% |
|
询价 |
32 |
2146095-13-6 |
Macropa-NH2 |
≥98% |
|
询价 |
33 |
2146095-31-8 |
Macropa-NCS |
≥98% |
|
询价 |
34 |
|
Dabigatran D4 HCl |
≥98% |
|
询价 |
35 |
2120398-41-4 |
CHK1-IN-4 |
≥98% |
|
询价 |
36 |
212201-70-2 |
Ipfencarbazone |
≥98% |
|
询价 |
37 |
212321-78-3 |
BIBR 1087 SE |
≥98% |
|
询价 |
38 |
212391-58-7 |
PP58 |
≥98% |
|
询价 |
39 |
2126819-55-2 |
Desmethyl-QCA276 |
≥98% |
|
询价 |
40 |
2127109-84-4 |
Ropsacitinib(PF-06826647 Tyk2-IN-8) |
≥98% |
|
询价 |
41 |
2130869-17-7 |
VCP-Eribulin |
≥98% |
|
询价 |
42 |
2130869-18-8 |
Mal-PEG2-VCP-Eribulin |
≥98% |
|
询价 |
43 |
2131803-90-0 |
WYC-209 |
≥98% |
|
询价 |
44 |
2133364-01-7 |
Vildagliptin dihydrate(LAF237 dihydrate NVP-LAF 237 dihydrate) |
≥98% |
|
询价 |
45 |
2133499-85-9 |
HSP27 inhibitor J2 |
≥98% |
|
询价 |
46 |
2134096-03-8 |
Almonertinib(HS-10296)hydrochloride |
≥98% |
|
询价 |
47 |
2136247-12-4 |
MD-224 |
≥98% |
|
询价 |
48 |
2137030-98-7 |
Ensartinib hydrochloride(X396) |
≥98% |
|
询价 |
49 |
2137047-43-7 |
VU6005649 |
≥98% |
|
询价 |
50 |
2138299-29-1 |
STING agonist-3 |
≥98% |
|
询价 |
51 |
2138299-33-7 |
diABZI STING agonist-1 |
≥98% |
|
询价 |
52 |
2138299-34-8 |
diABZI STING agonist-1 trihydrochloride |
≥98% |
|
询价 |
53 |
2138300-40-8 |
STING agonist-4 |
≥98% |
|
询价 |
54 |
2138498-18-5 |
diABZI STING agonist-3 |
≥98% |
|
询价 |
55 |
2140-46-7 |
25-Hydroxycholesterol |
≥98% |
|
询价 |
56 |
21411-53-0 |
Virginiamycin M1 |
≥98% |
|
询价 |
57 |
2143467-62-1 |
BPK-29 |
≥98% |
|
询价 |
58 |
2118944-88-8 |
FL-411 |
≥98% |
|
询价 |
59 |
211914-50-0 |
Dabigatran ethyl ester hydrochloride |
≥98% |
|
询价 |
60 |
130408-77-4 |
A 71623 |
≥98% |
|
询价 |